![Differential Diagnosis, Genetic Testing & Patient-centric Therapy](https://assets.radcliffecardiology.com/s3fs-public/podcast/2024-03/DELV-15829_BMS_Parallax_3_SoundCloud_3000x3000.png?VersionId=DUwMxCE2MrPO8TXWVZXT4SjT7caI2k_f)
In the finale of our series "Conversations about Hypertrophic Cardiomyopathy", Dr Ankur Kalra welcomes, Dr Anjali Tiku Owens, for a dynamic and practical discussion.
Dr Owens is Medical Director of the Center for Inherited Cardiac Disease and Associate Professor of Medicine at the Hospital of the University of Pennsylvania.
This series is supported by an unrestricted educational grant from Bristol Myers Squibb. Please see www.camzyosrems.com for important safety information.
In this week’s episode, Dr Kalra and Dr Owens take us on a journey through the complexities of hypertrophic cardiomyopathy (HCM), with focus on the diagnostic challenges and breakthroughs in this field.
Emphasising with the critical importance of making accurate diagnoses, Dr Owens shares her insights into identifying the common mimickers of HCM through a structured approach starting with taking the patients history.
As the conversation delves deeper, Dr Owens discusses the various diagnostic tools and tests used to rule out other conditions and uncover the underlying aetiology. She navigates us through the algorithm for interpreting genetic test results, differentiating pathogenic variants, benign variants and variants of uncertain significance (VUS). Dr Owens talks about the wider implications for family members and the cases in which she recommends screening.
Dr Kalra asks Dr Owens about her approach to exercise in HCM patients. Additionally, they cover the debated topic of defibrillator therapy and the use of HCM Risk-SCD risk calculator.
Dr Owens provides an overview of the treatment paradigms for HCM, touching on haemodynamic classifications, symptomatology and the evaluation of sudden death risk.
What are the most common mimickers of HCM? What is Dr Owens and her heart team approach to decision making? What is the role of genetic testing in patients with HCM?
This content is intended for US-based physicians.
This series is supported by an unrestricted educational grant from Bristol Myers Squibb.
![EP 98: Hospital of the Future: AI, Sensors & Sustainability with Dr Jag Singh](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2023-08/1920x1080_Web_Artwork_Parallax_EP98.png?VersionId=wiYrMU9b4F4N2FTqRNoDhiARcjvk.EPF&itok=fyj91_rY)
As we adapt to the changes brought about by the pandemic, Dr Singh outlines the necessary steps to foster a reality in which we can utilize these technologies to create more time for human connection.
![EP 117: Transforming Cardiac Surgery Recovery: Evidence-Based Insights with Dr Gerdisch](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-08/DELV-23187_IND_Parallax_EP117_Gerdisch_Web_1920x1080.jpg?VersionId=10jQcg6sZufXOZ_V2.eXBcL2gcTGQckL&itok=QUtGQF0H)
Dr Gerdisch shares insights into his research on rigid sternal fixation and enhanced recovery protocols, which have shown promising results in postoperative pain management and patient recovery.
![EP 116: Navigating the Realities of Guideline Directed Medical Therapy with Dr Chahoud and Dr Israel](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-07/DELV-17584_ZOLL_Parallax_3_Web_1920x1080_0.jpg?VersionId=7AsAfHb6JltTsIeGvFIL8PjSD_bJZQC7&itok=dAPVGO1r)
![EP 115: Navigating Cultures and Cardiology: Dr Janarthanan Sathananthan's Global Journey](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-07/DELV-22085_IND_Parallax_EP116_Sathananthan_Web_1920x1080.jpg?VersionId=X7UeGqRVZ0MB.gLJ_K0aoLflMIJqb8X.&itok=QOEUH6cW)
![The Leap Year Gene with Shelley Wood, Bestselling Author & Editor-in-Chief of TCTmd](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-06/DELV-21301_Parallax_EP114_Wood_Web_1920x1080.jpg?VersionId=o3p3VftF1kaRvWNWKzolgCRXyALPXFHt&itok=H2D2X7SD)
![EP 113: Your Guide to Radiation Hygiene: Insights from Manufacturer and Users](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-06/DELV-21795_Parallax_EP113_Breininger_Radtke_Web_1920x1080.jpg?VersionId=3d524UUeTRRuHi6Y8NqMN5n1WUksM6HI&itok=Eh3lMH-C)
![EP 112: Just One Heart: Burnout, Positive Mindset & Leadership with Dr Fisher](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-05/DELV-21579_Parallax_EP112_Fisher_Web_1920x1080.jpg?VersionId=NH6WDl3W2YJSM8.eRkQN4vq5MY2xbfEd&itok=tVbLnj0V)
![EP 111: ACC 24 in Review With Dr Vallabhajosyula: 5 Trials That Will Change Your Practice](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-04/DELV-21011_Parallax_EP111_Vallabhajosyula_Web_1920x1080.jpg?VersionId=ZOcxXpbfxpQgrVCl9j7I92zCplTgt1mZ&itok=LmOEuJkd)
![EP 110: Cultivating Leadership, Civic Duty & the Presidential Leadership Programme with Dr Sinha](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-04/DELV-20782_IND_Parallax_Sinha_Web_1920x1080-2.png?VersionId=o5_ez0NqChSi.6qI0.I0LGPQ4LmwK.Ac&itok=jmdoA2eD)
![EP 109: Navigating Volume Status in Heart Failure Patients with Dr Andrew Darlington](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-03/DELV-17583_ZOLL_Parallax_2_Web_1920x1080.jpg?VersionId=bavAruPc_yuREgwZwQomlSmR8bzSje6U&itok=ybL6yurd)
Together, Dr Kalra and Dr Darlington delve into the significance of assessing volume status in patients with heart failure, highlighting its continued relevance in 2024, including the availability of new diagnostic tools, including the Heart Failure Management System (HFMS).
This series is supported by ZOLL and is intended for Health Care Professionals.
![EP 108: Song of Our Scars: Authorship & Medicine with Senior Advisor for FDA, Dr Warraich](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/DELV-19380_IND_Parallax_EP108_Warraich_Web_1920x1080.jpg?VersionId=HPs.636T_kpikJm7DK8VEDs5f0aphHbL&itok=Nh_OhD_E)
![High-Sensitivity Cardiac Troponin ACS](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-02/Parallax-Podcast-w-Athena-%20Poppas_0.png?VersionId=uAw7s0xUwfjE1_1xcLbM7odh7YHQJw7K&itok=pSrlvyyg)
Chest pain is one of the most common reasons for an emergency room visit in the US, with almost 6 million ER visits annually, yet there is no consensus on how to compare the results from various hscTn assays. Tune in to hear Santiago outline the advantages and limitations of using hscTn as a standard biomarket to evaluate patients with suspected ACS in the ER.
Hosted by @AnkurKalraMD. Produced by @RadcliffeCardiology.
![01: Conduction Abnormalities After TAVR/TAVI With Chad Kliger](https://assets.radcliffecardiology.com/s3fs-public/styles/podcast_episode_teaser/public/podcast-episode/2024-03/Parallax_01_1200x628.jpg?VersionId=8YtGXyCvpISHGUAWuUfXgEArl7M4TInv&itok=fTCIJSke)